Categories Uncategorized

What You Should Know About Traumatic Brain Injuries and PTSD

Brain injuries usually occur when an individual is involved in some trauma such as a fall, a blast or an accident while traumatic brain injuries occur from a sudden jolt or blow to the head. Traumatic brain injuries can be severe, moderate or mild, and are similar to concussions. Oftentimes, when individuals refer to traumatic brain injuries, they talk about the symptoms that occur following the injury, forgetting the fact that a traumatic brain injury is an actual injury.

Nearly 80% of all traumatic brain injuries in people are considered mild, with a majority of these patients fully recovering in three months without the need for special treatment. Sometimes, patients with severe or moderate traumatic brain injuries also make exceptional recoveries.

Symptoms resulting from a traumatic brain injury are referred to as post-concussion syndrome. Some individuals display all the symptoms while some only exhibit one or a few. The most common symptoms following a traumatic brain injury can be categorized as emotional, mental and physical.

Emotional symptoms include changes in personality, anxiety, anger outbursts and depression while mental symptoms include trouble putting thoughts into words, acting without thinking, poor judgement, trouble with being focused and memory issues. Physical symptoms include noise and light sensitivity, vision problems, sleep problems, fatigue, dizziness and headaches. In addition, severe cases may experience seizures and reduced response to standard medications.

Since traumatic brain injuries are caused by trauma, some patients may also develop post-traumatic stress disorder (“PTSD”). Post-traumatic stress disorder is a mental health condition that is brought about by experiencing distressing, frightening or stressful events and/or witnessing said events.

Most traumatic brain injury symptoms are similar to those of PTSD, which may make it harder for physicians to diagnose the injury. Symptoms of PTSD include severe anxiety, severe emotional distress, issues with one’s memory, negative thoughts about oneself or others, trouble sleeping, concentration problems, change in one’s personality, outbursts of anger and irritability as well as self-destructive behavior.

PTSD’s symptoms usually vary in intensity as time goes by, which makes it even more important for individuals who may have been injured to be diagnosed by a skilled clinician. Clinicians note that it is important to be evaluated because the effects of the injury could be severe, no matter how mild the injury itself was. In addition, individuals with traumatic brain injuries shouldn’t use some medications as they may do more harm than good.

With companies such as Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) actively studying compounds such as ibogaine for their efficacy in the treatment of TBI, an effective remedy could be on the horizon.

NOTE TO INVESTORS: The latest news and updates relating to Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) are available in the company’s newsroom at http://ibn.fm/MCURF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Study Identifies Genetic Marker Helpful in Guiding Brain Tumor Treatment

Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams…

21 hours ago

New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease

Computer scientists have designed an AI-based speech screening tool that could help people ascertain whether…

2 days ago

Why Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Is ‘One to Watch’

Izotropic is the only commercial entity with exclusive global rights to the Breast CT technology…

4 days ago

Study Discovers That Autoantibodies in Patients Could Boost Cancer Immunotherapy

For years, oncologists have been baffled by why checkpoint inhibitors work for some cancer patients…

4 days ago

Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate

Clene is progressing toward a potential FDA accelerated approval for its ALS (Amyotrophic Lateral Sclerosis)…

5 days ago

Survey Finds That US Healthcare Workers Worry About Personal Safety

According to a new survey, approximately 60% of workers in the U.S. healthcare sector are…

1 week ago